Introduction
Blood transfusion service has been considered to be an integral part of the health care system in every country. The mission is to supply safe blood in adquate quantity with affordable costs to those who are in need. The procurement of blood in industrialized countries, as shown Leikola, was 5 times that in middle income countries and 50 times that in low income countries. The procurement of blood in most developing countries still does not reach the minimal target recommended by WHO, ie. 2% of the population per year.
Thailand is a country in Southeast Asia, bordering by the Indian Ocean and Myanmar in the West, Cambodia and Laos in the East, Laos and Myanmar in the North, Malaysiaand the Gulf of Thailand in the South. The country's total area is approximately 518 000 sq. kms (202,000 sq. mi) and its population is nearly 60 million. The capital is Bandkok in which there are approximately 5.5 million inhabitants.
In the past, health care system in the country was covered mostly by government clinics and hospitals. Presently, private sector begins to take share in health care system, especially in Bangkok.
Of 99, 000 hospital beds throughout the country, 22, 000 are in Bangkok; 6, 000 of which are privately owned. 
National

Collection of Blood and Component Preparation
Whole blood from first time donors are collected 300 ml in bottles. Those from repeat donors are collected 450 ml in plastic double or tripple bags. Bottles, though imported, cost less than plastic bags, and also can be re-used. With a high positive rate (about 8%) of transmissible diseases, e.g. HBsAg. HCV, HIV among first time donors, using bottles help reducing wastage. Blood components, however, can not be prepared from bottles. Collection of blood mostly is from non-remunerated general donations; about 17% are from replacement donation. Annual collection in 1993 was 890,000 units throughout the country, 270,000 of which was from Bangkok. An average rate of collection per population of the country was still below 2%. However, rate per population of Bangkok was about 5.5%.
At the National Blood Center, 70% of blood collection are from mobile buses going to the donors' workplaces. Three different sizes of bus are used. Big coach is convenient but expensive. Minibus is cost effective but requires working space at the workplace which are hardly available at present. About 45% of total whole blood collection are seperated into other four essential blood components at the National Blood Center, i.e. packed red cells, platelet concentrates, fresh frozen plasma and cryoprecipitates.
Specialized blood products, e.g. frozen red cells, single donor platelet concentrates, irradiated blood products, have been developed at the National Blood Center recently. Donor recruitment depends very much on community leaders. About 75% of blood donor in this country are male and 25% are female. The age limit for first time donation are 16-60 years. Those engaged in risk behavior, e.g. IV drug users, male homosexuals, prison inmates, prostitutes, are excluded from donating blood.
Most common blood group is"0"(38%); least common is"AB"(7%); in between are"B" (34%) and "A" (21%). Rh-negative (of all ABO group) is 0.3%, which is much lower than the caucasian donors. This poses some problems to Rh-negative patients when request is on emergency basis.
Routine
Blood Screening
Before 1985, routine blood screening consisted of tests for syphilis and HBsAg. Currently, standard blood screening includes syphilis, HBsAg, anti-HCV, and anti-HIV.
The results are as follows: For all donation, the positive rate for HBsAg was 2.02%; anti-HCV was 0.62%, VDRL was 0.44% and anti-HIV was 0.39%. The positive rate was highest among first time male donors; being HBsAg, 7.64%; anti-HCV, 1.9%; VDRL, 1.1%; and anti-HIV, 1.6%.
Currently 6, 000 cases of AIDS and ARC have been reported; 18 of which were due to transfusion (before screening). Transfusion thus contributed only 0.3% of total AIDS cases.
There has been verbally reported of at least 10 cumulative cases of HIV infection from screened blood in 1991. HIV antigen screening was therefore implemented since September 1, 1991 to maximize safety of blood in the country. Antibody negative, antigen positive rate is currently about 3/100, 000.
Donor Self Exclusion
Self exclusion through questionnaires are also implemented. The anti-HIV positive rate among those who answered"unsafe"was 2.48%, significantly higher than those who answered"safe" (0.46%). The result was, however, not applicable.
Clinical Use of Blood and Components
Clinicians in this country still prefer to use whole blood than blood components, especially the surgeons. Many surgeons still request fresh whole blood. Only 45% of whole blood collection are then seperated into blood components to cover the needs. Seventy seven per cent of the request are for volume replacement. Top of the list is gastrointestinal hemorrhage. Next are trauma and accident, Obstetric and Gynecological problems, and elective surgery. Twenty three per cent of the request are for hematological diseases, e.g. anemia, thrombocytopenia, and hemophilia. Thalassemia is the major cause of anemia which requires blood transfusion in this country. While frozen cryoprecipitates are used for the treatment of hemophilia in Bangkok and nearby provinces, lyophilized fresh plasma is the product of choice for home treatment program of hemophiliacs. Purified factor-8 is very expensive imported product which has been rarely used in this country. HIV infection is therefore uncommon among hemophiliacs in Thailand.
The demand for platelet concentrates increases rapidly in recent years, especially for oncologic patients. 
